<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00716235</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-08-5185-LG-CTIL</org_study_id>
    <nct_id>NCT00716235</nct_id>
  </id_info>
  <brief_title>Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities</brief_title>
  <official_title>Characterization of Executive Functions and Patterns of Eye Movements in Children With Developmental Disabilities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bar-Ilan University, Israel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the profile of executive functions and eye&#xD;
      movements in several populations of children with developmental disabilities.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Abnormal Executive function (EF) profile was considered a major characteristic of Attention&#xD;
      deficit / hyperactivity disorder (ADHD) and autism, and is frequently implicated in&#xD;
      Developmental coordination disorder (DCD) children as well. The scientific literature implies&#xD;
      that the EF profile among these three groups share some common abnormalities, but differ&#xD;
      significantly in specific features. Abnormal EF profile may be a core feature of the&#xD;
      developmental trajectory of each syndrome.&#xD;
&#xD;
      The fine measurement of eye movements may shed light on the underlying mechanisms of specific&#xD;
      disorders, and point to abnormal attention, information processing, or motor organization.&#xD;
      Gaze is an important component of social interaction. Eye contact and recognition of other's&#xD;
      gaze direction are crucial to empathy assessment.&#xD;
&#xD;
      The current study will embark in the assessment of a wide range of EF in these populations&#xD;
      and in a matched control group, as well as their relation to other important parameters such&#xD;
      as daily function skills and comorbid neurobehavioral characteristics. It will also assess&#xD;
      the pattern of eye movements in response to various visual stimuli in these populations. The&#xD;
      main purpose is to characterize the similarities and differences of each of these&#xD;
      populations, in terms of EF and eye movements.&#xD;
&#xD;
      Assessment methods:&#xD;
&#xD;
      Clinical parameters:&#xD;
&#xD;
        -  Intelligence tests (according to the child's age)&#xD;
&#xD;
        -  Communication: DSM-IV, ADOS, Stony Brook questionnaire&#xD;
&#xD;
        -  Motor / Coordination: Movement Advanced Battery for Children (M-ABC)&#xD;
&#xD;
        -  Attention: Conners Rating Scales - Revised (CRS-R 3rd ed.)&#xD;
&#xD;
        -  Sleep: Sleep habits questionnaire&#xD;
&#xD;
      Executive functions will be assessed using the following methods:&#xD;
&#xD;
        -  NEPSI-II&#xD;
&#xD;
        -  BRIEF questionnaire&#xD;
&#xD;
        -  Wisconsin Card Sorting Test&#xD;
&#xD;
        -  Tower of Hanoi&#xD;
&#xD;
      Eye movements will be measured using an infra-red video camera produced by ISCAN inc. the&#xD;
      following visual stimuli will be presented:&#xD;
&#xD;
        -  Human faces presenting various emotions&#xD;
&#xD;
        -  Various objects&#xD;
&#xD;
        -  Saccade and anti-saccade tasks&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <condition>Autistic Disorder</condition>
  <condition>Developmental Coordination Disorder</condition>
  <arm_group>
    <arm_group_label>DCD</arm_group_label>
    <description>Children with a diagnosis of DCD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Autism</arm_group_label>
    <description>Children with a diagnosis of Autism disorder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADHD</arm_group_label>
    <description>Children with a diagnosis of ADHD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Control group - children with no neurological or psychiatric problems</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of 4-10 years&#xD;
&#xD;
          -  A medical diagnosis according to the relevant study group&#xD;
&#xD;
          -  Normal vision without glasses or contact lens.&#xD;
&#xD;
        Exclusion Criteria - clinical groups:&#xD;
&#xD;
          -  Intelligence Quotient below 70&#xD;
&#xD;
          -  A known brain damage&#xD;
&#xD;
          -  A known hearing impairment&#xD;
&#xD;
          -  Regular use of medications (except for psychostimulants)&#xD;
&#xD;
          -  Evidence for a known genetic syndrome&#xD;
&#xD;
          -  History of fetal CMV infection, birth asphyxia, major head injury or epilepsy&#xD;
&#xD;
        Exclusion Criteria - control group:&#xD;
&#xD;
          -  Intelligence Quotient below 70&#xD;
&#xD;
          -  Regular use of medications&#xD;
&#xD;
          -  Evidence for a neurological / psychiatric disorder, birth injury, developmental delay,&#xD;
             head injury, or other medical disorders that affect the central nervous system&#xD;
&#xD;
          -  Family History - first degree) of autism, DCD, ADHD or other neurological/psychiatric&#xD;
             disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidia Gabis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sheba Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lidia Gabis, MD</last_name>
    <phone>+972-3-5302236</phone>
    <email>lidia.gabis@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raanan Raz, Ph.D</last_name>
    <phone>+972-3-5302236</phone>
    <email>Raanan.Raz@sheba.health.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Weinberg Child Development Center, Sheba Medical Center, Tel-Hashomer</name>
      <address>
        <city>Ramat-Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.iscaninc.com/</url>
    <description>ISCAN Inc. - producing the eye tracking equipment for the study</description>
  </link>
  <verification_date>January 2009</verification_date>
  <study_first_submitted>July 15, 2008</study_first_submitted>
  <study_first_submitted_qc>July 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2008</study_first_posted>
  <last_update_submitted>January 15, 2009</last_update_submitted>
  <last_update_submitted_qc>January 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Lidia Gabis</name_title>
    <organization>Sheba Medical Center</organization>
  </responsible_party>
  <keyword>ADHD</keyword>
  <keyword>ASD</keyword>
  <keyword>PDD</keyword>
  <keyword>DCD</keyword>
  <keyword>Executive Functions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Developmental Disabilities</mesh_term>
    <mesh_term>Motor Skills Disorders</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>July 19, 2009</submitted>
    <returned>August 26, 2009</returned>
    <submitted>September 13, 2009</submitted>
    <returned>September 18, 2009</returned>
    <submitted>September 22, 2009</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>September 30, 2009</submitted>
    <returned>November 4, 2009</returned>
    <submitted>June 28, 2018</submitted>
    <submission_canceled>June 28, 2018</submission_canceled>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

